Michael Grissinger's Net Worth

$6.42 Thousand

Estimate Recalculated Nov 3, 2024 09:37PM EST

Who is Michael Grissinger?

Michael Grissinger does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include resTORbio, Inc., Aprea Therapeutics, Inc., and Akari Therapeutics Plc.

SEC CIK

Michael Grissinger's CIK is 0001757601

Past Insider Trading and Trends

2024 was Michael Grissinger's most active year for acquiring shares with 3 total transactions. Michael Grissinger's most active month to acquire stocks was the month of May. 2024 saw Michael Grissinger paying a total of $0.00 for 5,005,230 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

resTORbio, Inc. (ACET) Snapshot price: $1.56

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
Nov 5
Form 3
—
0
—
—
0
No matching records found

Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+130.79%
1.04K
—
—
1.84K
Jun 20
Form 4
+167.22%
500
—
—
799
Aug 23
Form 4
∞
6K
—
—
6K
Jul 28
Form 3
—
0
—
—
0
No matching records found

Akari Therapeutics Plc (AKTX) Snapshot price: $3.69

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 28
Form 3
—
0
—
—
0
No matching records found